英文名稱： Sunitinib

中文名稱： 舒尼替尼

MF： C26H31FN4O6

MW： 514.55

CAS： 557795-19-4

中文名稱:舒尼替尼

中文同義詞:SU-11248;SU11248;蘋果酸舒尼替尼/舒尼替尼/舒馬替尼/;舒尼替尼(索坦);1H-吡咯-3-甲酰胺,N-[2-(二乙氨基)乙基]-5-[(Z)-(5-氟-1,2-二氫-2-氧代-3H-吲哚-3-亞基)甲基]-2,4-二甲基-;SUNI錫IB;舒尼替尼及其中間體;舒尼替尼及中間體;舒尼替尼堿(標(biāo)準(zhǔn)品)

英文名稱:Sunitinib

英文同義詞:N-[2-DiethylaMino(ethyl-d4)]-5-[(Z)-(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)Methyl]-2,4-diMethyl-1H-pyrrole-3-carboxaMide;SU-11248-d4;Sutent-d4;(Z)-N-(2-(DiethylaMino)ethyl)-5-((5-fluoro-2-oxoindolin-3-ylidene)Methyl)-2,4-diMethyl-1H-pyrrole-3-carboxaMide;Sunitinib(MixtureofEandZIsoMer);SunitinibN-(2-(Diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-Chemicalbook2-oxo-3H-indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3-carboxamide;Sunitinib,>=99%;sunitinib

CAS號(hào):557795-19-4

分子式:C26H31FN4O6

分子量:514.55

相關(guān)類別:抗腫瘤藥物;原料藥;抗癌藥;醫(yī)藥中間體;抗腫瘤類藥物及免疫抑制劑;多靶點(diǎn)抗腫瘤藥物;抗癌類;小分子抑制劑;小分子抑制劑，天然產(chǎn)物;抗腫瘤類;蛋白酪氨酸激酶;醫(yī)藥原料;醫(yī)藥原料藥;TINIBS替尼類產(chǎn)品(Anti-cancer);抗癌藥物;對(duì)照品-雜質(zhì)對(duì)照品;對(duì)照品;SU-11248;Inhibitors;TyrosineKinaseInhibitors;Pharmaceuticalintermediate;API;IsotopeLabelledCompounds;ActivePharmaceuticalIngredients;Sunitinib;MolecularTargetedAntineoplastic;HeterocyclicCompounds;anti-neoplastic;Heterocycles;Intermediates&FineChemicals;Pharmaceuticals